Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 08.06.2026 1 Acta Obstet Gynecol Scand 1 Acta Oncol 1 Afr J Prim Health Care Fam Med 1 Ann Med 1 Biochem Biophys Res Commun 1 Biol Direct 1 Biomed Res Int 1 BMC Med Imaging 1 BMC Nutr 1 BMJ 1 Cancer Control 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Med 1 Cancer Sci 1 Clin J Oncol Nurs 2 Discov Oncol 1 Eur J Cancer 1 Eur Rev Med Pharmacol Sci 1 Facts Views Vis Obgyn 1 Front Biosci (Landmark Ed) 1 Front Med (Lausanne) 4 Front Oncol 1 Gynecol Oncol 2 Gynecol Oncol Rep 1 Hum Vaccin Immunother 1 Immunopharmacol Immunotoxicol 2 Indian J Surg Oncol 2 Int J Gynecol Cancer 1 IUBMB Life 1 J Cancer Educ 1 J Contemp Brachytherapy 5 J Gynecol Oncol 1 J Med Imaging Radiat Oncol 1 J Obstet Gynaecol Res 1 J Public Health (Oxf) 1 JACC Case Rep 2 Med J Malaysia 1 Mol Cell Biochem 1 Nihon Hoshasen Gijutsu Gakkai Zasshi 2 Nutr Rev 1 Obstet Gynecol Clin North Am 1 Oncol Res 1 PeerJ 1 PLoS One 1 Radiat Oncol 1 Radiat Prot Dosimetry 1 Radiol Phys Technol 1 S Afr Med J 2 Sci Rep 1 Sex Health

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. KYLLONEN S, Saloranta S, Kares S, Mustila A, et al
   Introducing self-sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland.
   Acta Obstet Gynecol Scand. 2026 Jun 4. doi: 10.1111/aogs.70273.
   PubMed         Abstract available
   
   

   
   Acta Oncol

2. BISCHOF K, Fredriksen KM, Bjornstad M, Elstrand MB, et al
   Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer - a Norwegian real-world cohort.
   Acta Oncol. 2026;65:518-524.
   PubMed         Abstract available
   
   

   
   Afr J Prim Health Care Fam Med

3. BOTO T, Feketshane AM, Ngxola N
   Evaluating knowledge and awareness of cervical cancer, human papillomavirus and human papillomavirus vaccination among women in East London, South Africa.
   Afr J Prim Health Care Fam Med. 2026;18:e1-e6.
   PubMed         Abstract available
   
   

   
   Ann Med

4. CHEN X, Xue Z, Zhao S, Sun L, et al
   Clinical manifestations and ultrasonographic features of lobular endocervical glandular hyperplasia: a retrospective study of 135 patients.
   Ann Med. 2026;58:2673627.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. WENG X, Zeng C, Lv J, Huang F, et al
   Exosomes derived from M2-polarized tumor-associated macrophages contribute to immune escape in cervical cancer.
   Biochem Biophys Res Commun. 2026;828:154046.
   PubMed         Abstract available
   
   

   
   Biol Direct

6. LIU T, Chen J, Dai B, Du D, et al
   TRIM71 suppresses cervical cancer progression by inhibiting Nectin4-mediated Wnt/beta-catenin signaling.
   Biol Direct. 2026 Jun 3. doi: 10.1186/s13062-026-00843.
   PubMed         Abstract available
   
   

   
   Biomed Res Int

7. DIAZ-OBREGON D, Paco-Fernandez M, Ladera-Castaneda M, Huamani-Contreras M, et al
   Implementation of HPV Self-Sampling in Cervical Cancer Screening Programs: A Bibliometric Analysis of Research Output, Global Trends, and Collaboration Networks.
   Biomed Res Int. 2026;2026:e9345778.
   PubMed         Abstract available
   
   

   
   BMC Med Imaging

8. XU S, Zou Y, Wu Z, Xu Z, et al
   Deep learning-based cervical cancer T-staging using MRI: multi-structure segmentation and classification.
   BMC Med Imaging. 2026 May 30. doi: 10.1186/s12880-026-02449.
   PubMed         Abstract available
   
   

   
   BMC Nutr

9. ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
   Nutritional status of patients diagnosed with cervical cancer in Tanzania.
   BMC Nutr. 2026 Jun 2. doi: 10.1186/s40795-026-01323.
   PubMed         Abstract available
   
   

   
   BMJ

10. PAPENBURG J, Pollock K, Yansouni CP
    Increasing participation in cervical cancer screening.
    BMJ. 2026;393:e353462.
    PubMed        
    
    

    
    Cancer Control

11. BOGART LM, Whitaker L, Gwokyalya V, Beyeza-Kashesya J, et al
    A Qualitative Analysis of Factors Contributing to Cervical Cancer Screening Implementation in Health Care Facilities in Uganda.
    Cancer Control. 2026;33:10732748261450722.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

12. STEFANOS R, Gargano JW, Niccolai LM, Castilho JL, et al
    Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.
    Cancer Epidemiol Biomarkers Prev. 2026;35:913-920.
    PubMed         Abstract available
    
    

    
    Cancer Med

13. ZHENG X, Pan D, Lin J, Xiao J, et al
    Analysis of Pathological Discrepancies Between Colposcopic Biopsy and Conization in Cytology-Positive Cervical Lesions.
    Cancer Med. 2026;15:e72002.
    PubMed         Abstract available
    
    

    
    Cancer Sci

14. KESHARWANI P, Nasir N, Wahab S, Gupta G, et al
    PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment.
    Cancer Sci. 2026 Mar 31. doi: 10.1111/cas.70361.
    PubMed         Abstract available
    
    

    
    Clin J Oncol Nurs

15. BROWN C, McNally GA
    The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.
    Clin J Oncol Nurs. 2026;30:231-235.
    PubMed         Abstract available
    
    

    
    Discov Oncol

16. TANG Y, Ning L, Yang X, Li N, et al
    Construction and validation of a novel prognostic risk model in cervical cancer: integrating lactylation-related genes linked to radiotherapy?associated transcriptional changes.
    Discov Oncol. 2026 Jun 3. doi: 10.1007/s12672-026-05351.
    PubMed         Abstract available
    
    
17. FAROOQI AA, Attar R, Gasparri ML, Berardi R, et al
    Emerging landscape of oncogenic signaling pathways in cervical cancer.
    Discov Oncol. 2026 Jun 4. doi: 10.1007/s12672-026-05271.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

18. ELLIS LB, Tighe J, Bowden SJ, Kechagias KS, et al
    Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2026;243:116823.
    PubMed         Abstract available
    
    

    
    Eur Rev Med Pharmacol Sci

19. SELVA RAJAN R, Dass SA, Sachit BA, Tye GJ, et al
    Development of a new diagnostic tool for detecting cervical cancer using a TCR-like antibody targeting the HPV 16 oncoprotein E7.
    Eur Rev Med Pharmacol Sci. 2026;30:164-180.
    PubMed         Abstract available
    
    

    
    Facts Views Vis Obgyn

20. FERLA S, De Gobbi V, Seracchioli R, Raimondo D, et al
    Laparoscopic cervical cerclage at 10 weeks gestation in a patient with an adverse obstetric history following fertility-sparing surgery for cervical cancer.
    Facts Views Vis Obgyn. 2026 Jun 1. doi: 10.52054/FVVO.2026.
    PubMed         Abstract available
    
    

    
    Front Biosci (Landmark Ed)

21. ANTANO-ARIAS R, Torres-Rojas FI, Campos-Viguri GE, Arizmendi-Izazaga A, et al
    miR-19a-3p as a Candidate oncomiRNA in Cervical Cancer: Insights From a Bioinformatic Analysis.
    Front Biosci (Landmark Ed). 2026;31:51227.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

22. WANG T, Zheng X, Chen B, Xiao R, et al
    Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches.
    Front Med (Lausanne). 2026;13:1777235.
    PubMed         Abstract available
    
    

    
    Front Oncol

23. MOUSSAVOU-BOUNDZANGA P, Ambounda NL, Zinsou BE, Bivigou-Mboumba B, et al
    Breast and cervical cancer screening in a semi-urban African setting: evidence from Franceville, Gabon (2015-2021).
    Front Oncol. 2026;16:1735802.
    PubMed         Abstract available
    
    
24. WANG Y, Jin X, Zhao S, Zhang Z, et al
    Trajectory changes of symptom clusters in patients with concurrent chemoradiotherapy for cervical cancer: a prospective longitudinal study.
    Front Oncol. 2026;16:1808208.
    PubMed         Abstract available
    
    
25. WANG Q, Li Y, Shen L, Zhang Y, et al
    Prediction of myelosuppression risk in postoperative cervical cancer patients undergoing concurrent chemoradiotherapy using machine learning models.
    Front Oncol. 2026;16:1800585.
    PubMed         Abstract available
    
    
26. PASSARELLA G, Vella S, Ferrario E, Provinciali N, et al
    Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.
    Front Oncol. 2026;16:1796299.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

27. WOLSWINKEL JT, Bekkers AHPA, Maurits JSF, Bekkers RLM, et al
    Preoperative LVSI assessment in early-stage cervical cancer: Can it reliably guide lymph node management?
    Gynecol Oncol. 2026;210:106-112.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

28. GARIN C, Daix M, Bresson L, Navarro AS, et al
    Step-by-step type III total pelvic exenteration with vaginectomy and partial vulvectomy with complex pelvic reconstruction for vaginal recurrence of cervical cancer.
    Gynecol Oncol Rep. 2026;65:102109.
    PubMed        
    
    
29. MANGA SM, Randolph I, Ugwu L, Lee G, et al
    Nurse-led visual triage against histopathology in a real-world low-resource setting cervical cancer prevention program.
    Gynecol Oncol Rep. 2026;65:102105.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

30. ANGELILLO S, Miraglia Del Giudice G, Della Polla G, Angelillo IF, et al
    Cervical cancer and screening: Knowledge, attitudes, and adherence among university students in Italy.
    Hum Vaccin Immunother. 2026;22:2682535.
    PubMed         Abstract available
    
    

    
    Immunopharmacol Immunotoxicol

31. 
    Statement of Retraction: Amygdalin Induces Apoptosis in Human Cervical Cancer Cell Line HeLa Cells.
    Immunopharmacol Immunotoxicol. 2026 Jun 3:1. doi: 10.1080/08923973.2026.2675070.
    PubMed        
    
    

    
    Indian J Surg Oncol

32. SHAH S, Shah D, Shah H, Parmar J, et al
    Outcomes of Pelvic Exenteration for Recurrent or Persistent Cervical Cancer: Revisiting Curative approach in the Era of Advancing Palliative Options.
    Indian J Surg Oncol. 2026;17:1045-1051.
    PubMed         Abstract available
    
    
33. RAJU K, Kukkamgai HM, Kamarthi PP
    Evolution of Cervical Cancer Screening Techniques: A Concept of Translation Medicine.
    Indian J Surg Oncol. 2026;17:1159-1170.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

34. TEODORICO E, Moro F, Criscione M, Culcasi C, et al
    Ultrasound detection of residual cervical cancer after conization, in a retrospective monocentric analysis: the URECA study.
    Int J Gynecol Cancer. 2026;36:104755.
    PubMed         Abstract available
    
    
35. LEVIN G, Gilbert L, Pareja R, Leung SOA, et al
    Impact of bilateral oophorectomy on survival among patients undergoing radical hysterectomy for cervical adenocarcinoma: a National Cancer Database analysis.
    Int J Gynecol Cancer. 2026;36:104469.
    PubMed         Abstract available
    
    

    
    IUBMB Life

36. HAMAD RS, Doghish AS, Abdel Mageed SS, Rizk NI, et al
    MicroRNAs in HPV-Associated Carcinogenesis: Potential Biomarkers in Oropharyngeal and Cervical Cancers.
    IUBMB Life. 2026;78:e70117.
    PubMed         Abstract available
    
    

    
    J Cancer Educ

37. HARGIS A, Berg CJ, Le D
    Knowledge, Attitudes, and Behaviors Regarding HPV Vaccination and Self-Sampling Among US Young Adults.
    J Cancer Educ. 2026;41:588-600.
    PubMed         Abstract available
    
    

    
    J Contemp Brachytherapy

38. MANIYAR AI, Alva RC, Koushik K, Nithyanand S, et al
    Enhancing brachytherapy in cervical cancer: Initial dosimetric experience and assessment of Tulip hybrid applicator - the Add-On advantage.
    J Contemp Brachytherapy. 2026;18:32-39.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

39. SUGAWARA M, Nishio H, Iwata T, Katoh Y, et al
    Establishment and genomic characterization of patient-derived organoids from gastric-type cervical adenocarcinoma.
    J Gynecol Oncol. 2026;37:e101.
    PubMed         Abstract available
    
    
40. IRIE G, Kobayashi Y, Shikama A, Yoshino M, et al
    Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.
    J Gynecol Oncol. 2026;37:e47.
    PubMed         Abstract available
    
    
41. WEI S, Li X, Liu Z, Wei L, et al
    Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.
    J Gynecol Oncol. 2026;37:e46.
    PubMed         Abstract available
    
    
42. NAKAZAWA M, Teramoto M, Saito T
    Therapeutic efficacy of laser vaporization and conization for high-grade cervical intraepithelial neoplasia.
    J Gynecol Oncol. 2026;37:e34.
    PubMed         Abstract available
    
    
43. CHIKAZAWA K, Fujimori A, Imai K, Ko H, et al
    Laparoscopic radical hysterectomy after the LACC trial, avoiding uterine manipulator, pre-colpotomy vaginal washing and clamping, and uterine removal using a retrieval bag: a retrospective study.
    J Gynecol Oncol. 2026;37:e40.
    PubMed         Abstract available
    
    

    
    J Med Imaging Radiat Oncol

44. MILLS D, Sridharan S, Govindarajulu G
    Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future Directions.
    J Med Imaging Radiat Oncol. 2026 Jun 2. doi: 10.1111/1754-9485.70130.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

45. YOSHIMURA T, Tatsuta I, Suzuki T, Tsuchino Y, et al
    Feasibility and Short-Term Outcomes of an endoCUT-Based Non-Ligation Cervical Conization Strategy: A Single-Center Retrospective Study.
    J Obstet Gynaecol Res. 2026;52:e70349.
    PubMed        
    
    

    
    J Public Health (Oxf)

46. IVERSEN L, Raja EA, Nath M, Lip G, et al
    The influence of rural residency on the uptake of screening for breast, cervical, and colorectal cancers in Scotland.
    J Public Health (Oxf). 2026;48:467-476.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

47. NOORANI S, Tang KS, Patel A, Tran D, et al
    Cancerous Arrhythmia: Metastatic Cervical Cancer to the Heart Complicated by Ventricular Tachycardia.
    JACC Case Rep. 2026 Jun 2:108560. doi: 10.1016/j.jaccas.2026.108560.
    PubMed         Abstract available
    
    

    
    Med J Malaysia

48. HAMID MR, Mohd Yunus N, Abdul Aziz AA, Azwari Annuar A, et al
    Genetic polymorphisms of XRCC1 on cervical cancer susceptibility risk.
    Med J Malaysia. 2026;81:356-361.
    PubMed         Abstract available
    
    
49. NOVIANTI L, Calvin D, Feharsal Y, Candrani FVD, et al
    Cervical cancer survival rate after abdominal vs. laparoscopic radical hysterectomy in two government hospitals in Jakarta, Indonesia.
    Med J Malaysia. 2026;81:337-342.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

50. HUANG L, Feng W, Long W, Liu H, et al
    Nobiletin attenuates self-renewal in cervical cancer cells and spheres through miR-342-3p upregulation and FOXM1 downregulation.
    Mol Cell Biochem. 2026 Jun 2. doi: 10.1007/s11010-026-05572.
    PubMed         Abstract available
    
    

    
    Nihon Hoshasen Gijutsu Gakkai Zasshi

51. AKAGAWA J, Sera T, Yuasa Y
    [Impact of Source Position Error in Tandem-ovoid Applicator on Dose Distribution in Cervical Cancer Brachytherapy].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2026;82.
    PubMed         Abstract available
    
    

    
    Nutr Rev

52. HUA Y, Li Y, Qin H, Huo M, et al
    Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
    Nutr Rev. 2026 Jun 2:nuag097. doi: 10.1093.
    PubMed        
    
    
53. GU X, Shen T, Guo XK
    Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.
    Nutr Rev. 2026 Jun 2:nuag096. doi: 10.1093.
    PubMed        
    
    

    
    Obstet Gynecol Clin North Am

54. MURPHY EC, Rowen TS
    Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.
    Obstet Gynecol Clin North Am. 2026;53:339-351.
    PubMed         Abstract available
    
    

    
    Oncol Res

55. KAO PY, Chen JH, Chen KH
    The Role of HPV and Hormone in Cervical Precancer and Cancer: Molecular Pathophysiology and Cell Biology of Disease and Treatment.
    Oncol Res. 2026;34:12.
    PubMed         Abstract available
    
    

    
    PeerJ

56. ZHAO G, Al Ramadhan MM, Zhang Y
    Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis.
    PeerJ. 2026;14:e21337.
    PubMed         Abstract available
    
    

    
    PLoS One

57. BUTTA J, Thonghoi P, Kesakul T, Thoopthong A, et al
    Incremental impact of community-delivered HPV self-sampling on screening uptake within an active outreach system: A quasi-experimental implementation study in rural Thailand.
    PLoS One. 2026;21:e0349531.
    PubMed         Abstract available
    
    

    
    Radiat Oncol

58. XU M, Kang K, Zhao M, Bi S, et al
    Optimizing ovarian dose sparing for young cervical cancer patients after oophoropexy: a dosimetric and radiobiological comparison of three radiotherapy techniques (IMPT, TOMO, and VMAT).
    Radiat Oncol. 2026 Jun 4. doi: 10.1186/s13014-026-02862.
    PubMed         Abstract available
    
    

    
    Radiat Prot Dosimetry

59. BILEK Y, Hakki Sarpun I, Koca T
    Can volumetric arc therapy be an alternative to brachytherapy in advanced cervical cancer radiotherapy?
    Radiat Prot Dosimetry. 2026;202:720-725.
    PubMed         Abstract available
    
    

    
    Radiol Phys Technol

60. LI B, Liu Y, Pan Y, Zhang Y, et al
    Dnq-unet: a two-level fusion framework for few-shot domain adaptation in cervical cancer CTV segmentation.
    Radiol Phys Technol. 2026 Jun 3. doi: 10.1007/s12194-026-01072.
    PubMed         Abstract available
    
    

    
    S Afr Med J

61. NAIDOO L, Nxele S, Yusuf-Saka T
    Enhancing cervical cancer screening coverage in selected primary healthcare sites using Lean thinking: The CerviScreen programme.
    S Afr Med J. 2026;116:e3654.
    PubMed         Abstract available
    
    

    
    Sci Rep

62. MARZHOSEYNI Z, Shayestehpour M, Shaghaghi Z, Alvandi M, et al
    Streptococcus-derived CpsA-CpsC fusion protein induces apoptosis in cervical cancer cells through in silico and in vitro methods.
    Sci Rep. 2026 May 30. doi: 10.1038/s41598-026-55464.
    PubMed         Abstract available
    
    
63. BAYKEMAGN ND, Alemu GG, Tewelgne MF, Bicha AT, et al
    Predicting knowledge of cervical cancer screening among reproductive-age women in sub-saharan africa using machine learning algorithms.
    Sci Rep. 2026 Jun 2. doi: 10.1038/s41598-026-54976.
    PubMed         Abstract available
    
    

    
    Sex Health

64. ZOU Z, Zhai B
    A systematic review of barriers to cervical cancer screening among Thai women based on the social ecological model: a multi-level analysis of local evidence.
    Sex Health. 2026;23:SH26059.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum